Sponsor
University of Nebraska
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name University of Nebraska appears in 170 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownAbi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate CancerNCT07237269 · lead sponsor · 2026-10-15
RECRUITINGPSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate CancerNCT07234981 · lead sponsor · 2026-03-31
RECRUITINGAttention and Eye Movement in Parkinson's DiseaseNCT06899022 · lead sponsor · 2025-09-22
RECRUITINGERAS Protocols in Breast Conserving SurgeryNCT06938581 · lead sponsor · 2025-07-11
RECRUITINGSCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial DiseaseNCT06480786 · lead sponsor · 2024-12-18
RECRUITINGThe Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)NCT06524856 · lead sponsor · 2024-10-01
RECRUITINGHEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection FractionNCT05784753 · lead sponsor · 2023-11-20
RECRUITINGHigh-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate CancerNCT05754580 · lead sponsor · 2023-08-29
RECRUITINGAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)NCT05070013 · lead sponsor · 2021-11-18
RECRUITINGNovel DBS Stimulation Patterns for Treatment of Parkinson's DiseaseNCT04799470 · lead sponsor · 2021-05-10
RECRUITINGBlood Markers of Early Pancreas CancerNCT03568630 · lead sponsor · 2018-07-26
RECRUITINGEarly Rheumatoid Arthritis Lung Disease StudyNCT03192267 · lead sponsor · 2017-03-31
RECRUITINGIntegrated Cancer Repository for Cancer ResearchNCT02012699 · lead sponsor · 2013-11-01
RECRUITINGTreatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseNCT03414502 · lead sponsor · 2007-12-10
RECRUITINGDe-escalation of Axillary Dissection for Node-positive Breast CancerNCT07856160 · lead sponsor · 2026-10-15
NOT_YET_RECRUITINGCommunity Support and Mobile Apps to Help Black Women Control High Blood Pressure After PregnancyNCT07606027 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGModulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPDNCT07703527 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGWhole Versus Partial Gland Boost During Prostate SBRTNCT07574489 · lead sponsor · 2026-07-25
NOT_YET_RECRUITINGCOQ10 and Vitamin E for Off-Target Radiation ToxicityNCT07668284 · lead sponsor · 2026-07-01
NOT_YET_RECRUITINGFeasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized NutritionNCT07194642 · lead sponsor · 2026-05-30
NOT_YET_RECRUITINGTrabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1NCT06579196 · lead sponsor · 2025-05-12
ACTIVE_NOT_RECRUITINGTheophylline Nasal Spray for PD-Related Hyposmia and AnosmiaNCT06498687 · lead sponsor · 2025-04-01
WITHDRAWNIMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan AreasNCT06451341 · lead sponsor · 2024-07-01
ACTIVE_NOT_RECRUITINGAssessing Continuous Glucose Monitor Use in Underserved Primary Care PatientsNCT05766488 · lead sponsor · 2023-07-24
ENROLLING_BY_INVITATIONThe Lymphoid Tissue Pharmacology of Antiretroviral DrugsNCT02707926 · lead sponsor · 2023-03-25
WITHDRAWNBiomarker Validation Following Sargramostim Treatment in Parkinson's DiseaseNCT05677633 · lead sponsor · 2023-01-19
COMPLETEDEffect of Computerized Cognitive Training in Persons With MSNCT05345288 · lead sponsor · 2022-06-28
COMPLETEDRural HEART Camp Connect: A Feasibility StudyNCT05647759 · lead sponsor · 2022-06-01
COMPLETEDHigh-intensity Exercise After TreatmentNCT04950010 · lead sponsor · 2022-03-28
TERMINATEDHEART Camp Connect: A Feasibility StudyNCT05985395 · lead sponsor · 2022-03-28
TERMINATEDClinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine TherapyNCT05069038 · lead sponsor · 2022-03-02
ACTIVE_NOT_RECRUITINGStrength, Aging, and Memory in Prostate CancerNCT04852224 · lead sponsor · 2021-10-01
COMPLETEDEvaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart TransplantationNCT05038943 · lead sponsor · 2021-09-15
COMPLETEDSafety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With DurvalumabNCT04748419 · lead sponsor · 2021-07-15
TERMINATEDPackaging Building Healthy Families for Community ImplementationNCT04719442 · lead sponsor · 2021-06-01
WITHDRAWNFamily Connections: Cultural Adaptation and Feasibility Testing for Rural Latino CommunitiesNCT04731506 · lead sponsor · 2021-06-01
TERMINATEDThe Patterns of Activity and Cognition During Treatment (PACT) StudyNCT04562987 · lead sponsor · 2021-01-15
COMPLETEDSafety and Effectiveness of NRP for DCD Heart TransplantationNCT04626284 · lead sponsor · 2021-01-03
COMPLETEDAdaptive Neurostimulation to Restore Sleep in Parkinson's DiseaseNCT04620551 · lead sponsor · 2020-10-21
COMPLETEDA Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLCNCT03963414 · lead sponsor · 2020-09-25
TERMINATEDLongitudinal Analysis of Gait Variability to Predict Falls in Parkinson's DiseaseNCT04339543 · lead sponsor · 2020-02-28
TERMINATEDValidity of Physical Activity Questionnaires in Persons Pursuing Bariatric SurgeryNCT03981978 · lead sponsor · 2020-01-01
COMPLETEDEffects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) PatientsNCT03514875 · lead sponsor · 2019-11-11
WITHDRAWNStudy on Physical Activity's Relationship With Cancer and CognitionNCT03980626 · lead sponsor · 2019-09-30
COMPLETEDSustaining the Reach of a Scalable Weight Loss Intervention Through Financial IncentivesNCT04225234 · lead sponsor · 2019-08-20
TERMINATEDUnderstanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom ExperienceNCT03724331 · lead sponsor · 2019-06-04
COMPLETEDMeasurement of Beta Cell Death in Individuals With Cystic FibrosisNCT03713437 · lead sponsor · 2019-04-04
COMPLETEDExergaming in Advanced HF With Multiple Chronic Conditions Prior to LVAD Implantation or Heart TransplantNCT03580759 · lead sponsor · 2019-03-01
COMPLETEDBiomarker Assessments of Leukine During Treatment of Parkinson's DiseaseNCT03790670 · lead sponsor · 2019-01-30
COMPLETEDExamining Reach and Implementation of an Evidence-based Weight Loss Program in Rural Primary CareNCT03690557 · lead sponsor · 2018-10-24
COMPLETEDLoop Duodenal Switch: Outcomes at One YearNCT03206736 · lead sponsor · 2018-08-09
TERMINATEDFacilitating Oncology Patient-Clinician Communication Via E-health InnovationsNCT03442127 · lead sponsor · 2018-01-31
COMPLETEDA Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender WomenNCT03270969 · lead sponsor · 2018-01-05
COMPLETEDRole of Circulating Innate Lymphoid Cells in Allergic DisordersNCT03069495 · lead sponsor · 2017-08-21
TERMINATEDReducing Distress and Depressive-symptoms in Rural WomenNCT03465813 · lead sponsor · 2017-07-19
COMPLETEDAssessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors ClinicNCT03431831 · lead sponsor · 2017-07-01
COMPLETEDFactors Affecting Aqueous Humor Outflow Facility in Patients with UveitisNCT02613442 · lead sponsor · 2017-04-13
WITHDRAWNPharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected WomenNCT02722421 · lead sponsor · 2017-04-06
COMPLETEDBest Incision Site for Obese Patients - Low Versus High TransverseNCT03041220 · lead sponsor · 2016-12-01
WITHDRAWNRanibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 StudyNCT02511067 · lead sponsor · 2016-10-01
WITHDRAWNSponsor roles
lead sponsor133
collaborator37
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.